| Supriya Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543434 |
NSE Symbol : SUPRIYA |
P/E(TTM) : 35.88 |
|
ISIN Demat : INE07RO01027 |
Div & Yield% : 0.11 |
EPS(TTM) : 24.69 |
|
Book Value(₹) : 148.82 |
Market Cap(₹Cr) : 7,129.17 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 189.75 | 276.53 | 206.44 | 199.83 | 145.07 | 184.11 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 189.75 | 276.53 | 206.44 | 199.83 | 145.07 | 184.11 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.65 | 3.48 | 2.61 | 2.73 | 2.67 | 2.98 |
| Total Income | 192.40 | 280.01 | 209.05 | 202.56 | 147.75 | 187.08 |
| Total Expenditure | 142.29 | 178.91 | 134.82 | 127.19 | 93.37 | 116.53 |
| PBIDT | 50.11 | 101.10 | 74.24 | 75.37 | 54.38 | 70.56 |
| Interest | 0.37 | 0.47 | 0.49 | 0.42 | 0.51 | 0.42 |
| PBDT | 49.73 | 100.63 | 73.74 | 74.96 | 53.86 | 70.14 |
| Depreciation | 8.94 | 8.50 | 6.82 | 6.64 | 6.45 | 6.08 |
| Tax | 8.51 | 20.42 | 15.32 | 15.16 | 10.54 | 12.77 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 8.24 | -2.52 | 1.92 | 2.73 | 2.09 | 0.91 |
| Reported Profit After Tax | 24.04 | 74.23 | 49.68 | 50.43 | 34.79 | 50.38 |
| Extra-ordinary Items | 0.00 | 0.00 | -0.34 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 24.04 | 74.23 | 50.02 | 50.43 | 34.79 | 50.38 |
| EPS (Unit Curr.) | 2.99 | 9.22 | 6.17 | 6.27 | 4.32 | 6.29 |
| EPS (Adj) (Unit Curr.) | 2.99 | 9.22 | 6.17 | 6.27 | 4.32 | 6.29 |
| Calculated EPS (Unit Curr.) | 2.99 | 9.22 | 6.17 | 6.27 | 4.32 | 6.26 |
| Calculated EPS (Adj) (Unit Curr.) | 2.99 | 9.22 | 6.17 | 6.27 | 4.32 | 6.26 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.95 | 36.89 | 24.69 | 25.06 | 17.29 | 25.04 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.95 | 36.89 | 24.69 | 25.06 | 17.29 | 25.04 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.10 | 16.10 | 16.10 | 16.10 | 16.10 | 16.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.41 | 36.56 | 35.96 | 37.72 | 37.49 | 38.32 |
| PBDTM(%) | 26.21 | 36.39 | 35.72 | 37.51 | 37.13 | 38.10 |
| PATM(%) | 12.67 | 26.84 | 24.07 | 25.24 | 23.98 | 27.36 |
